These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17599217)

  • 1. Steady growth in antiretroviral treatment provision by disease management and community treatment programmes.
    Johnson LF; McLeod HD
    S Afr Med J; 2007 May; 97(5):358-9. PubMed ID: 17599217
    [No Abstract]   [Full Text] [Related]  

  • 2. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    Boulle A; Van Cutsem G; Hilderbrand K; Cragg C; Abrahams M; Mathee S; Ford N; Knight L; Osler M; Myers J; Goemaere E; Coetzee D; Maartens G
    AIDS; 2010 Feb; 24(4):563-72. PubMed ID: 20057311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of adult antiretroviral treatment coverage in South Africa.
    Adam MA; Johnson LF
    S Afr Med J; 2009 Sep; 99(9):661-7. PubMed ID: 20073293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAMA takes the lead in HAART provision.
    Bateman C
    S Afr Med J; 2002 Oct; 92(10):750-1. PubMed ID: 12432791
    [No Abstract]   [Full Text] [Related]  

  • 5. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
    Ojikutu B; Jack C; Ramjee G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S523-7. PubMed ID: 18181705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV in South Africa.
    Satoh S; Boyer E
    Lancet; 2019 Aug; 394(10197):467. PubMed ID: 31402024
    [No Abstract]   [Full Text] [Related]  

  • 7. ARV compliance--the new battle terrain.
    Bateman C
    S Afr Med J; 2004 Aug; 94(8):602-3, 605. PubMed ID: 15352575
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric highly active antiretroviral therapy in Africa: potential benefits of a family-centered model.
    Reddi A; Leeper SC; Sunpath H
    J Infect Dis; 2008 Sep; 198(6):938-9; author reply 939-40. PubMed ID: 18721063
    [No Abstract]   [Full Text] [Related]  

  • 9. Inspiring rural health--a fierce and distant light.
    Bateman C
    S Afr Med J; 2006 Jul; 96(7):576-7. PubMed ID: 16909173
    [No Abstract]   [Full Text] [Related]  

  • 10. Situational analysis of varying models of adherence support and loss to follow up rates; findings from 27 treatment facilities in eight resource limited countries.
    Etienne M; Burrows L; Osotimehin B; Macharia T; Hossain B; Redfield RR; Amoroso A
    Trop Med Int Health; 2010 Jun; 15 Suppl 1():76-81. PubMed ID: 20586964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inevitability of antiretrovirals.
    S Afr Med J; 2003 Aug; 93(8):572. PubMed ID: 14531106
    [No Abstract]   [Full Text] [Related]  

  • 12. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.
    Long L; Fox M; Sanne I; Rosen S
    AIDS; 2010 Mar; 24(6):915-9. PubMed ID: 20042849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twitchy health department "bungles" global AIDS report.
    Bateman C
    S Afr Med J; 2006 Jun; 96(6):488-92. PubMed ID: 16841127
    [No Abstract]   [Full Text] [Related]  

  • 14. Community-based management of multidrug-resistant tuberculosis in South Africa.
    Bekker LG; Wood R
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):379. PubMed ID: 20202291
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa.
    Wouters E; Van Damme W; van Rensburg D; Meulemans H
    AIDS; 2008 Nov; 22(18):2545-8. PubMed ID: 19005281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The motivations for participation in public-private partnerships for the provision of tuberculosis treatment in South Africa.
    Sinanovic E; Kumaranayake L
    Glob Public Health; 2010; 5(5):479-92. PubMed ID: 19479590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
    Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
    J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antiretroviral treatment and counselling on disclosure of HIV-serostatus in Johannesburg, South Africa.
    Skogmar S; Shakely D; Lans M; Danell J; Andersson R; Tshandu N; Odén A; Roberts S; Francois Venter WD
    AIDS Care; 2006 Oct; 18(7):725-30. PubMed ID: 16971281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing HIV prevention science: the roads from Cape Town.
    Mayer KH
    Lancet; 2014 Nov; 384(9956):1725-7. PubMed ID: 25455236
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral therapy in the private sector of Nairobi, Kenya: a review of the experience of five physicians.
    Macharia DK; Chang LW; Lule G; Owili DM; Tesfaledet G; Patel S; Silverstein DM; Ng'ang'a L; Bush T; De Cock KM; Weidle PJ
    AIDS; 2003 Apr; 17(6):938-40. PubMed ID: 12660550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.